Novo Nordisk A/S (NVO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 117.53 |
| Open | 119.92 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 900 |
| Day's range | 119.48 - 120.56 |
| 52-week range | 92.94 - 148.15 |
| Volume | |
| Avg. volume | 4,094,856 |
| Market cap | 535.154B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 40.83 |
| EPS (TTM) | 2.94 |
| Earnings date | 06 Nov 2024 |
| Forward dividend & yield | 1.45 (1.21%) |
| Ex-dividend date | 16 Aug 2024 |
| 1y target est | 142.92 |
Insider MonkeyHere’s What Dragged Novo Nordisk A/S (NVO) in Q3
Baird Asset Management controlled Chautauqua Capital Management, a boutique investment firm, released the “Baird Chautauqua International and Global Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The third quarter saw a significant rally in global equities markets, driven by robust stock performance from the U.S., international developed, […]
Yahoo FinanceWeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.
Investor's Business DailyIs Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
© 2024 Yahoo. All rights reserved.